Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An infiltrating transitional cell carcinoma that arises from the renal pelvis and exhibits sarcomatoid features.
1 clinical trial registered. Interventions under study include procedural interventions and biologic therapy. Pipeline includes 1 EARLY_PHASE1. Research is primarily sponsored by academic and government institutions.
4 publications have been identified in PubMed for kidney pelvis sarcomatoid transitional cell carcinoma. Research spans Case Report / Case Series (75%) and Other (25%).
Bolous Y (2025). [PMID: 39380364](https://pubmed.ncbi.nlm.nih.gov/39380364/). *International journal of surgical pathology*. [Case Report / Case Series]
Rikitake R (2025). [PMID: 40376725](https://pubmed.ncbi.nlm.nih.gov/40376725/). *Pathol Int*. [Other]
Yang ZP (2024). [PMID: 39551743](https://pubmed.ncbi.nlm.nih.gov/39551743/). *BMC urology*. [Case Report / Case Series]
Norton SM (2024). [PMID: 39437508](https://pubmed.ncbi.nlm.nih.gov/39437508/). *Int J Surg Case Rep*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:05 PM UTC